StonvexLoading…
StonvexStonvexStonvexCore line items from DNLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $330.53M | $105.06M |
Operating Income | $-555.34M | $-487.34M | $-196.70M | $-340.74M |
Net Income | $-512.54M | $-422.77M | $-145.22M | $-325.99M |
EPS (Diluted) | $-2.97 | $-2.57 | $-1.06 | $-2.60 |
Total Assets | $1.14B | $1.37B | $1.15B | $1.46B |
Total Liabilities | $131.09M | $144.50M | $122.96M | $417.81M |
Cash & Equivalents | $205.33M | $174.96M | $127.11M | $218.04M |
Free Cash Flow OCF − CapEx | $-422.10M | $-363.61M | $-370.93M | $-262.55M |
Shares Outstanding | 156.18M | 144.22M | 138.39M | 135.97M |